AstraZeneca has resumed its clinical trial of a potential coronavirus vaccine, following an interruption due to a possible side effect.
The trial was paused after a patient developed an ‘unexplained illness.’ No details were revealed about the patient’s status or the nature of the illness.
The vaccine, even if successful in its trials, might not be available for the wider population until 2022 at the earliest.
Tell us your thoughts in the Facebook post and share this with your friends.